Denosumab in the treatment of delayed hypercalcemia after rhabdomyolysis

Background/objective: Rhabdomyolysis-associated hypercalcemia has limited management options in oliguric patients. Our objective is to describe a case of refractory rhabdomyolysis-associated hypercalcemia with concomitant anuria that was treated with denosumab. Case presentation: A 57-year-old woman...

Full description

Bibliographic Details
Published in:Journal of Clinical and Translational Endocrinology Case Reports
Main Authors: Nabil W.G. Sweis, Ahmed Noor, Karen Jong, Joseph L. Zapater
Format: Article
Language:English
Published: Elsevier 2025-09-01
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2214624525000127